Jon P Stonehouse insider trades

Open-market stock purchases and sales by Jon P Stonehouse, Director at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Mar 1, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +139%.

Recent trades

DateStockTradeValue
Aug 31, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$6.2K
Jun 11, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Jun 11, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
May 29, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$5.6K
Mar 2, 2026BCRX Biocryst Pharmaceuticals IncSold (not open market)$2.6M
Mar 2, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Feb 27, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$3.7K
Dec 19, 2025BCRX Biocryst Pharmaceuticals IncSold (not open market)$458K
Dec 18, 2025BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Dec 18, 2025BCRX Biocryst Pharmaceuticals IncSold (not open market)—
Dec 12, 2025BCRX Biocryst Pharmaceuticals IncSold (not open market)$207K
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)$946K

Companies traded

  • BCRX Biocryst Pharmaceuticals Inc: 4 buys, 9 sales, last Aug 31, 2026
  • MTSR Metsera, Inc: other filings, last Nov 13, 2025
  • BLCM Bellicum Pharmaceuticals, Inc: 1 buy, last Jan 3, 2023

Get free alerts when Jon P Stonehouse files a new trade →